Compare Alcon AG (ALC) vs Planet Labs (PL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Planet Labs — how do they compare? Alcon AG trades at $67.62 (market cap $32.08B), while Planet Labs trades at $16.27 (market cap $5.99B). The key difference: Alcon AG is far larger — about 5.4× Planet Labs's market cap, and Alcon AG pays a 0.54% dividend while Planet Labs pays none. Which is the better fit depends on your goals.
| ALC | PL | |
|---|---|---|
Market Cap | $32.08B | $5.99B |
Sector | Health | Technology |
52-Week High | $87.18 | $51.40 |
52-Week Low | $62.02 | $9.75 |
Enterprise Value | $35.92B | $5.62B |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.03, down 0.78% on the day, with a bearish technical signal from moving averages despite bullish oscillators. The company reported Q2 2026 EPS of $0.84, beating expectations, and raised its 2026 profit outlook. Revenue grew to $10.40B in 2025, though net income margin dipped to 5.92%. Analyst consensus is bullish with a $85.85 price target, supported by new product launches like the UNITY M microscope and tariff relief reducing cost pressures.
Outlook: ALC's strong fundamentals and raised guidance present upside potential, but risks include intense competition and margin pressure. The stock's current valuation at 50.4x P/E requires sustained earnings growth to justify further gains, with institutional interest highlighted by Bill Ackman's recent position.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Planet Labs
Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →
